Veradermics (MANE) Shares Outstanding (2024 - 2026)

Veradermics (MANE) has 3 years of Shares Outstanding (Entity) data on file, last reported at $22.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2980.89% year-over-year to $22.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.7 million (up 2980.89% YoY) and the FY2025 annual result came in at $749760.0, up 1.74% from the prior year.
• Shares Outstanding (Entity) climbed to $22.7 million in Q1 2026, from $749760.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $22.7 million in Q1 2026 to a low of $736933.0 in Q4 2024.
• A 3-year average of $6.2 million and a median of $743346.5 in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) advanced 1.74% — and 2026, when it surged 2980.89%.
• Tracing MANE's Shares Outstanding (Entity) over 3 years: stood at $736933.0 in 2024, then increased by 1.74% to $749760.0 in 2025, then jumped by 2928.19% to $22.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $22.7 million (Q1 2026), $749760.0 (Q4 2025), and $736933.0 (Q1 2025), per Business Quant data.